R. Kerry Clark - 14 May 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: Director
Issuer ticker: ELV
Reported as of: 14 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 May 2025, 16:14:19 UTC
Prior SEC filing: 25 Apr 2025
Next SEC filing: 01 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

R. Kerry Clark filed Form 4 for Elevance Health, Inc. (ELV) on 16 May 2025.

Key facts

This page summarizes R. Kerry Clark's Form 4 filing for Elevance Health, Inc. (ELV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 May 2025, 16:14.

Change

Previous filing in this sequence was filed on 25 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001180776 Primary reporting owner

CLARK R KERRY

Relationship: Director
Address: 220 VIRGINIA AVENUE, INDIANAPOLIS
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Signature date: 16 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Award

Transaction value: $0
Shares: +601
Change %: +6.6%
Price: $0.000000
Shares after: 9,640
Date: 14 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

Footnote F2

The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.